Michael Glover is a Biopharma Executive at Qinexa. He possess expertise in pharmaceutical industry, market access, strategy, diabetes, team management and 30 more skills. Colleagues describe him as "I'd like to recommend Mike for his demonstrated leadership as Director, Global Market Access Lead for Metabolics. His knowledge of metabolics and global markets, strategic thinking and willingness to collaborate allowed Mike to lead key initiatives to assist Key Markets entry of new products, resulting in minimizing barriers and alternate solutions for success. I truly enjoyed collaborating with Mike and wish him true success in future endeavors.", "Mike worked alongside my organisation on a number of pieces of work over three years. He was able not only to communicate succinctly, but listen carefully, with an intuitive grasp of complexity. He has an natural ability to network and bring people together on a common cause. His depth of knowledge of the health systems, and the people that lead and work within it, was second to none. He offered a wealth of experience which he presented in an understated way, often with an innovative view or solution. It was no surprise that he was taken on to greater things in the US, he offers open and helpful advice, support and practical solutions.His focus, drive, natural leadership and creativity will help any organisation that he works for, or is working with him.", and "Mike's move from BMS UK is a loss for our UK organisation, but a great gain for our Global colleagues. Mike is one of the most creative people I have worked with - his depth of insight and experience means he can be relied upon to approach a problem from a different perspective, resulting in innovative solutions that really meet the needs of stakeholders. He is direct, trustworthy and engaging, which explains his success in building an impressive professional network of contacts and partners, including policymakers, professional associations and government clinical advisors. He is very supportive of colleagues, both professionally and personally, and I am confident that he will quickly become a huge asset to his new team, helping them to meet their commercial objectives."